EX-10.2
from 8-K
7 pages
April 27, 2026 Andreas Rolf Muehler Re: Transition, Separation, and Consulting Agreement 1. Separation Date. Subject to the Terms and Conditions of This Agreement, Your Employment With the Company Will Continue Through April 30, 2026, Which Will Become Your Employment Termination Date (The “Separation Date”). 2. Title. Your Title Will Be Changed From Chief Medical Officer to Senior Medical Officer on the Date of This Agreement. as of the Date of This Agreement, You Will Report to the Newly Appointed Chief Medical Officer of the Company
12/34/56
EX-10.1
from 8-K
25 pages
Immunic, Inc. 2019 Omnibus Equity Incentive Plan, as Amended on June 28, 2023, March 4, 2024, and June 4, 2025
12/34/56